Lv11
22 积分 2023-10-08 加入
GPRC5D as a novel immunotherapeutic target in multiple myeloma
2小时前
已完结
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
2小时前
已完结
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
6天前
已完结
BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
2个月前
已完结
Elranatamab: a new promising BispAb in multiple myeloma treatment
6个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
6个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
8个月前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
11个月前
已完结
Mechanoimmunology in the solid tumor microenvironment
11个月前
已完结
In vivo CAR engineering for immunotherapy
11个月前
已完结
皖公网安备34019202002308
